Sunday, June 4, 2023
SCIENMAG: Latest Science and Health News
No Result
View All Result
  • Login
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
No Result
View All Result
Scienmag - Latest science news from science magazine
No Result
View All Result
Home SCIENCE NEWS Chemistry AND Physics

Recently discovered protein domain regulates collagen transport

May 22, 2023
in Chemistry AND Physics
0
Share on FacebookShare on Twitter

How collagen reaches its site of action

Moth

Credit: Ian Glaves

How collagen reaches its site of action

Almost all organisms that have more than one cell require collagen to hold their bodies together. In some mammals, it accounts for up to 30 per cent of body weight. Collagen is a huge protein that is produced in the so-called endoplasmic reticulum, an organelle inside cells. It then has to be exported from the organelle and from the cell, because it is needed in the space between the cells in the connective tissue.

A family of proteins known as TANGO1 is responsible for identifying and transporting the collagen. Made up of more than 1,000 amino acids, these proteins are very large indeed. TANGO1 proteins sometimes spread across various cell organelles and the cytoplasm. When the TANGO1 protein detects a maturating collagen, it supports the formation of a tunnel-like lipid connection that transports the collagen from its place of manufacture to its site of action.

A distinct structure

In order to perform these mechanisms, TANGO1 has a specific domain, i.e. a functional area with a defined 3D structure. “Up to now, we have assumed that this domain is similar to the so-called SH3 structure and regarded it as a substructure,” says Raphael Stoll. In the current study, however, he and Oliver Arnolds demonstrated by means of NMR spectroscopy that there are structural differences between the collagen-recognition domain of TANGO1 and the canonical SH3 domain. These differences are so significant in terms of biochemistry that they warrant referring to this TANGO1 domain as a separate structure. Hence, they named this collagen-recognising domain MOTH. “The name is an acronym for the total of four proteins that adopt exactly this structure: MIA, Otoraplin, TALI/TANGO1 homology,” explains Raphael Stoll.

The discovery of the MOTH domain provides insights into evolution, because both vertebrates and invertebrates such as insects need collagen. “The MOTH domain is very old in evolutionary terms, approximately several hundred million years,” points out Raphael Stoll. However, as invertebrates separated from vertebrates, the domain changed during evolution. “We assume that this process has coincided with the evolution of several different collagens. While insects have only one collagen, humans are found to have 28 different variations of it. These findings help improve our understanding of the collagen export process and could prove useful in future drug developments for fibrosis,” concludes Stoll.



Journal

Nature Communications

DOI

10.1038/s41467-023-37705-4

Method of Research

Computational simulation/modeling

Subject of Research

Cells

Article Title

Characterization of a fold in TANGO1 evolved from SH3 domains for the export of bulky cargos

Article Publication Date

20-Apr-2023

Tags: collagendiscovereddomainproteinregulatestransport
Share25Tweet16Share4ShareSendShare
  • Nearly 70% of private label avocado oil rancid or mixed with other oils

    65 shares
    Share 26 Tweet 16
  • Null results research now published by major behavioral medicine journal

    782 shares
    Share 313 Tweet 196
  • UC Davis C-STEM trains Redlands teachers on bringing computer science into math

    65 shares
    Share 26 Tweet 16
  • Mozart may reduce seizure frequency in people with epilepsy

    67 shares
    Share 27 Tweet 17
  • The promise of novel FolRα-targeting antibody drug conjugate in recurrent epithelial ovarian cancer

    64 shares
    Share 26 Tweet 16
  • Phase 3 SWOG Cancer Research Network trial, led by a City of Hope researcher, demonstrates one-year progression-free survival in 94% of patients with Stage 3 or 4 classic Hodgkin lymphoma who received a checkpoint inhibitor combined with chemotherapy

    64 shares
    Share 26 Tweet 16
ADVERTISEMENT

About us

We bring you the latest science news from best research centers and universities around the world. Check our website.

Latest NEWS

Null results research now published by major behavioral medicine journal

Why expensive wine appears to taste better

Element creation in the lab deepens understanding of surface explosions on neutron stars

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 206 other subscribers

© 2023 Scienmag- Science Magazine: Latest Science News.

No Result
View All Result
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US

© 2023 Scienmag- Science Magazine: Latest Science News.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In